A vaccinator attracts a Pfizer-BioNTech coronavirus illness (COVID-19) pediatric vaccine in Lansdale, Pennsylvania, U.S., December 5, 2021.
Hannah Beier | Reuters
The Meals and Drug Administration on Tuesday approved a Pfizer booster dose for kids ages 5 by 11 years previous.
Dr. Peter Marks, head of the FDA division accountable for vaccines, mentioned vaccine effectiveness wanes over time after the second dose. The FDA decided that the advantages of a 3rd dose within the 5 to 11 age group outweigh the dangers, Marks mentioned.
FDA Commissioner Robert Califf mentioned though Covid tends to be much less extreme in kids, extra children have been getting sick and hospitalized with virus for the reason that omicron variant grew to become dominant within the U.S. over the winter.
That is breaking information. Please verify again for updates.
